The pancreatic islets of Langerhans play a critical role in maintaining blood glucose
homeostasis by secreting insulin and several other important peptide hormones.
Impaired insulin secretion due to islet dysfunction is linked to the pathogenesis
underlying both Type 1 and Type 2 diabetes. Over the past 5 years, emerging
proteomic technologies have been applied to dissect the signaling pathways that
regulate islet functions and gain an understanding of the mechanisms of islet
dysfunction relevant to diabetes. Herein, we briefly review some of the recent
quantitative proteomic studies involving pancreatic islets geared towards gaining a
better understanding of islet biology relevant to metabolic diseases.
Revised: September 14, 2011 |
Published: August 1, 2011
Citation
Zhou J., G.P. Dann, C.W. Liew, R.D. Smith, R.N. Kulkarni, and W. Qian. 2011.Unraveling pancreatic islet biology by quantitative proteomics.Expert Review of Proteomics 8, no. 4:495-504.PNNL-SA-77799.doi:10.1586/epr.11.39